SIGA TECHNOLOGIES INC
Develops antiviral drugs for global health security against biothreats and infectious diseases.
SIGA | US
Overview
Corporate Details
- ISIN(s):
- US8269171067
- LEI:
- Country:
- United States of America
- Address:
- 31 EAST 62ND STREET, 10065 NEW YORK
- Website:
- https://www.siga.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
SIGA Technologies, Inc. is a commercial-stage pharmaceutical company focused on global health security. The company develops and commercializes solutions for serious infectious diseases, biothreats, and other unmet medical needs. Its lead product is TPOXX® (tecovirimat), an oral antiviral drug developed to treat smallpox and other related viruses. SIGA's primary mission is to provide countermeasures against emerging infectious diseases and potential biological weapons, contributing to public health and safety.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all SIGA TECHNOLOGIES INC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for SIGA TECHNOLOGIES INC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for SIGA TECHNOLOGIES INC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
